Viking Therapeutics’s $287.5 Million IPO

Martina Bellini
Tagged:

Mintz advised the syndicate of underwriters on the deal.Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now